Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peitu Qingxin (PTQX) granules for pediatric atopic dermatitis (Phase II, dose-exploration)
ChiCTR2000037991Phase 2Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Pei Tu Qing Xin in atopic dermatitis (AD) (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: SCORAD score. Started May 2020; status: recruiting.
02
Drugs
Pei Tu Qing Xin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2000037991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037991.